Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Increased level of acute phase reactants in patients infected with modern Mycobacterium tuberculosis genotypes in Mwanza, Tanzania

Authors: Ruth Stavrum, George PrayGod, Nyagosya Range, Daniel Faurholt-Jepsen, Kidola Jeremiah, Maria Faurholt-Jepsen, Henrik Krarup, Martine G Aabye, John Changalucha, Henrik Friis, Aase B Andersen, Harleen MS Grewal

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

There is increasing evidence to suggest that different Mycobacterium tuberculosis lineages cause variations in the clinical presentation of tuberculosis (TB). Certain M. tuberculosis genotypes/lineages have been shown to be more likely to cause active TB in human populations from a distinct genetic ancestry. This study describes the genetic biodiversity of M. tuberculosis genotypes in Mwanza city, Tanzania and the clinical presentation of the disease caused by isolates of different lineages.

Methods

Two-hundred-fifty-two isolates from pulmonary TB patients in Mwanza, Tanzania were characterized by spoligotyping, and 45 isolates were further characterized by mycobacterium interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR). The patients’ level of the acute phase reactants AGP, CRP and neutrophil counts, in addition to BMI, were measured and compared to the M. tuberculosis lineage of the infectious agent for each patient.

Results

The most frequent genotype was ST59 (48 out of 248 [19.4%]), belonging to the Euro-American lineage LAM11_ZWE, followed by ST21 (CAS_KILI lineage [44 out of 248 [17.7%]). A low degree of diversity (15.7% [39 different ST’s out of 248 isolates]) of genotypes, in addition to a high level of mixed M. tuberculosis sub-populations among isolates with an unreported spoligotype pattern (10 out of 20 isolates [50.0%]) and isolates belonging to the ST53 lineage (13 out of 25 [52%]) was observed. Isolates of the ‘modern’ (TbD1-) Euro-American lineage induced higher levels of α1-acid glycoprotein (β = 0.4, P = 0.02; 95% CI [0.06-0.66]) and neutrophil counts (β = 0.9, P = 0.02; 95% CI [0.12-1.64]) and had lower BMI score (β = -1.0, P = 0.04; 95% CI[-1.89 – (-0.03)]). LAM11_ZWE (‘modern’) isolates induced higher levels of CRP (β = 24.4, P = 0.05; 95% CI[0.24-48.63]) and neutrophil counts (β = 0.9, P = 0.03; 95% CI[0.09-1.70]).

Conclusion

The low diversity of genotypes may be explained by an evolutionary advantage of the most common lineages over other lineages combined with optimal conditions for transmission, such as overcrowding and inadequate ventilation. The induction of higher levels of acute phase reactants in patients infected by ‘modern’ lineage isolates compared to ‘ancient’ lineages may suggest increased virulence among ‘modern’ lineage isolates.
Literature
1.
go back to reference Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, et al: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998, 393: 537-544. 10.1038/31159.CrossRefPubMed Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, et al: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998, 393: 537-544. 10.1038/31159.CrossRefPubMed
2.
go back to reference Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M: Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS One. 2010, 5: e10753-10.1371/journal.pone.0010753.CrossRefPubMedPubMedCentral Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M: Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS One. 2010, 5: e10753-10.1371/journal.pone.0010753.CrossRefPubMedPubMedCentral
3.
go back to reference Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell PC, Small PM: Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006, 103: 2869-2873. 10.1073/pnas.0511240103.CrossRefPubMedPubMedCentral Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell PC, Small PM: Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006, 103: 2869-2873. 10.1073/pnas.0511240103.CrossRefPubMedPubMedCentral
4.
go back to reference Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM: Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci U S A. 2004, 101 (14): 4871-4876. 10.1073/pnas.0305627101.CrossRefPubMedPubMedCentral Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM: Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci U S A. 2004, 101 (14): 4871-4876. 10.1073/pnas.0305627101.CrossRefPubMedPubMedCentral
5.
go back to reference Hanekom M, van der Spuy GD, Streicher E, Ndabambi SL, McEvoy CRE, Kidd M, Beyers N, Victor TC, van Helden PD, Warren RM: A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol. 2007, 45: 1483-1490. 10.1128/JCM.02191-06.CrossRefPubMedPubMedCentral Hanekom M, van der Spuy GD, Streicher E, Ndabambi SL, McEvoy CRE, Kidd M, Beyers N, Victor TC, van Helden PD, Warren RM: A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol. 2007, 45: 1483-1490. 10.1128/JCM.02191-06.CrossRefPubMedPubMedCentral
6.
go back to reference Grange JM, Kardjito T, Setiabudi I: A study of acute-phase reactant proteins in Indonesian patients with pulmonary tuberculosis. Tubercle. 1984, 65 (1): 23-39. 10.1016/0041-3879(84)90027-8.CrossRefPubMed Grange JM, Kardjito T, Setiabudi I: A study of acute-phase reactant proteins in Indonesian patients with pulmonary tuberculosis. Tubercle. 1984, 65 (1): 23-39. 10.1016/0041-3879(84)90027-8.CrossRefPubMed
7.
go back to reference Haghighi LC: Reactive Protein in Pulminary Tuberculosis. CHEST J Am College Chest Physicians. 1966, 50 (6): 624- Haghighi LC: Reactive Protein in Pulminary Tuberculosis. CHEST J Am College Chest Physicians. 1966, 50 (6): 624-
8.
go back to reference Hernández-Pando R, Arriaga AK, Panduro CA, Orozco EH, Larriva-Sahd J, Madrid-Marina V: The response of hepatic acute phase proteins during experimental pulmonary tuberculosis. Exp Mol Pathol. 1998, 65 (1): 25-36. 10.1006/exmp.1998.2224.CrossRefPubMed Hernández-Pando R, Arriaga AK, Panduro CA, Orozco EH, Larriva-Sahd J, Madrid-Marina V: The response of hepatic acute phase proteins during experimental pulmonary tuberculosis. Exp Mol Pathol. 1998, 65 (1): 25-36. 10.1006/exmp.1998.2224.CrossRefPubMed
9.
go back to reference Jensen AV, Jensen L, Faurholt-Jepsen D, Aabye MG, Praygod G, Kidola J, Faurholt-Jepsen M, Changalucha J, Range N, Krarup H, Friis H, Andersen AB: The prevalence of latent Mycobacterium tuberculosis infection based on an interferon-γ release assay: a cross-sectional survey among urban adults in Mwanza, Tanzania. PLoS One. 2013, 8: e64008-10.1371/journal.pone.0064008.CrossRefPubMedPubMedCentral Jensen AV, Jensen L, Faurholt-Jepsen D, Aabye MG, Praygod G, Kidola J, Faurholt-Jepsen M, Changalucha J, Range N, Krarup H, Friis H, Andersen AB: The prevalence of latent Mycobacterium tuberculosis infection based on an interferon-γ release assay: a cross-sectional survey among urban adults in Mwanza, Tanzania. PLoS One. 2013, 8: e64008-10.1371/journal.pone.0064008.CrossRefPubMedPubMedCentral
10.
go back to reference WHO: Global Tuberculosis Control. 2013, Geneva: World Health Organization WHO: Global Tuberculosis Control. 2013, Geneva: World Health Organization
11.
go back to reference Chonde TM, Basra D, Mfinanga SGM, Range N, Lwilla F, Shirima RP, van Deun A, Zignol M, Cobelens FG, Egwaga SM, van Leth F: National anti-tuberculosis drug resistance study in Tanzania. Int J Tuberc Lung Dis. 2010, 14: 967-972.PubMed Chonde TM, Basra D, Mfinanga SGM, Range N, Lwilla F, Shirima RP, van Deun A, Zignol M, Cobelens FG, Egwaga SM, van Leth F: National anti-tuberculosis drug resistance study in Tanzania. Int J Tuberc Lung Dis. 2010, 14: 967-972.PubMed
12.
go back to reference WHO: Tuberculosis Programme Fact sheet. 1996, Geneva: World Health Organization WHO: Tuberculosis Programme Fact sheet. 1996, Geneva: World Health Organization
13.
go back to reference Wandwalo ER, Mørkve O: Delay in tuberculosis case-finding and treatment in Mwanza, Tanzania. Int J Tuberc Lung Dis Int Union Against Tuberc Lung Dis. 2000, 4 (2): 6- Wandwalo ER, Mørkve O: Delay in tuberculosis case-finding and treatment in Mwanza, Tanzania. Int J Tuberc Lung Dis Int Union Against Tuberc Lung Dis. 2000, 4 (2): 6-
14.
go back to reference Thwaites G, Caws M, Chau TTH, D’Sa A, Lan NTN, Huyen MNT, Gagneux S, Anh PTH, Tho DQ, Torok E, Nhu NTQ, Duyen NTH, Duy PM, Richenberg J, Simmons C, Hien TT, Farrar J: Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol. 2008, 46: 1363-1368. 10.1128/JCM.02180-07.CrossRefPubMedPubMedCentral Thwaites G, Caws M, Chau TTH, D’Sa A, Lan NTN, Huyen MNT, Gagneux S, Anh PTH, Tho DQ, Torok E, Nhu NTQ, Duyen NTH, Duy PM, Richenberg J, Simmons C, Hien TT, Farrar J: Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol. 2008, 46: 1363-1368. 10.1128/JCM.02180-07.CrossRefPubMedPubMedCentral
15.
go back to reference Rakotosamimanana N, Raharimanga V, Andriamandimby SF, Soares J-L, Doherty TM, Ratsitorahina M, Ramarokoto H, Zumla A, Huggett J, Rook G, Richard V, Gicquel B, Rasolofo-Razanamparany V: Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clin Vaccine Immunol. 2010, 17: 1094-1103. 10.1128/CVI.00049-10.CrossRefPubMedPubMedCentral Rakotosamimanana N, Raharimanga V, Andriamandimby SF, Soares J-L, Doherty TM, Ratsitorahina M, Ramarokoto H, Zumla A, Huggett J, Rook G, Richard V, Gicquel B, Rasolofo-Razanamparany V: Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clin Vaccine Immunol. 2010, 17: 1094-1103. 10.1128/CVI.00049-10.CrossRefPubMedPubMedCentral
16.
go back to reference National Bureau of Statistics (URT): Mwanza Regional and District Projections. 2006, Mwanza, Tanzania: National Bureau of Statistics (URT) National Bureau of Statistics (URT): Mwanza Regional and District Projections. 2006, Mwanza, Tanzania: National Bureau of Statistics (URT)
17.
go back to reference Jeremiah K, Praygod G, Faurholt-Jepsen D, Range N, Andersen AB, Grewal HMS, Friis H: BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine?. Thorax. 2010, 65: 1072-1076. 10.1136/thx.2010.134767.CrossRefPubMed Jeremiah K, Praygod G, Faurholt-Jepsen D, Range N, Andersen AB, Grewal HMS, Friis H: BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine?. Thorax. 2010, 65: 1072-1076. 10.1136/thx.2010.134767.CrossRefPubMed
18.
go back to reference Faurholt Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt Jepsen M, Aabye MG, Changalucha J, Christensen DL, Pipper CB, Krarup H, Witte DR, Andersen AB, Friis H: Diabetes is a risk factor for pulmonary tuberculosis: a case–control study from Mwanza, Tanzania. PLoS One. 2011, 6: e24215-10.1371/journal.pone.0024215.CrossRefPubMedPubMedCentral Faurholt Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt Jepsen M, Aabye MG, Changalucha J, Christensen DL, Pipper CB, Krarup H, Witte DR, Andersen AB, Friis H: Diabetes is a risk factor for pulmonary tuberculosis: a case–control study from Mwanza, Tanzania. PLoS One. 2011, 6: e24215-10.1371/journal.pone.0024215.CrossRefPubMedPubMedCentral
19.
go back to reference Van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993, 31: 406-409.PubMedPubMedCentral Van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993, 31: 406-409.PubMedPubMedCentral
20.
go back to reference van Embden JDA, Schouls LM, van Soolingen D: “Molecular Techniques: Applications in Epidemiologic Studies.” Mycobacterium Bovis Infection in Animals and Humans. 1995, Ames: Iowa State University Press, 15-27. van Embden JDA, Schouls LM, van Soolingen D: “Molecular Techniques: Applications in Epidemiologic Studies.” Mycobacterium Bovis Infection in Animals and Humans. 1995, Ames: Iowa State University Press, 15-27.
21.
go back to reference Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J: Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997, 35: 907-914.PubMedPubMedCentral Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J: Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997, 35: 907-914.PubMedPubMedCentral
22.
go back to reference Gagneux S, Small PM: Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis. 2007, 7 (5): 328-337. 10.1016/S1473-3099(07)70108-1.CrossRefPubMed Gagneux S, Small PM: Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis. 2007, 7 (5): 328-337. 10.1016/S1473-3099(07)70108-1.CrossRefPubMed
23.
go back to reference Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuño L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de Viedma D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, et al: Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 2006, 6 (1): 23-10.1186/1471-2180-6-23.CrossRefPubMedPubMedCentral Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuño L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de Viedma D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, et al: Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 2006, 6 (1): 23-10.1186/1471-2180-6-23.CrossRefPubMedPubMedCentral
24.
go back to reference Lazzarini LCO, Rosenfeld J, Huard RC, Hill V, Silva L e, DeSalle R, Rastogi N, Ho JL: Mycobacterium tuberculosis spoligotypes that may derive from mixed strain infections are revealed by a novel computational approach. Infect Genet Evol. 2012, 12: 798-806. 10.1016/j.meegid.2011.08.028.CrossRefPubMed Lazzarini LCO, Rosenfeld J, Huard RC, Hill V, Silva L e, DeSalle R, Rastogi N, Ho JL: Mycobacterium tuberculosis spoligotypes that may derive from mixed strain infections are revealed by a novel computational approach. Infect Genet Evol. 2012, 12: 798-806. 10.1016/j.meegid.2011.08.028.CrossRefPubMed
25.
go back to reference Stavrum R, Mphahlele M, Øvreas K, Muthivhi T, Fourie PB, Weyer K, Grewal HMS: High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 isolates. J Clin Microbiol. 2009, 47: 1848-1856. 10.1128/JCM.02167-08.CrossRefPubMedPubMedCentral Stavrum R, Mphahlele M, Øvreas K, Muthivhi T, Fourie PB, Weyer K, Grewal HMS: High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 isolates. J Clin Microbiol. 2009, 47: 1848-1856. 10.1128/JCM.02167-08.CrossRefPubMedPubMedCentral
26.
go back to reference Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D: Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006, 44: 4498-4510. 10.1128/JCM.01392-06.CrossRefPubMedPubMedCentral Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D: Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006, 44: 4498-4510. 10.1128/JCM.01392-06.CrossRefPubMedPubMedCentral
27.
go back to reference Vitol I, Driscoll J, Kreiswirth B, Kurepina N, Bennett KP: Identifying Mycobacterium tuberculosis complex strain families using spoligotypes. Infect Genet Evol. 2006, 6 (6): 491-504. 10.1016/j.meegid.2006.03.003.CrossRefPubMed Vitol I, Driscoll J, Kreiswirth B, Kurepina N, Bennett KP: Identifying Mycobacterium tuberculosis complex strain families using spoligotypes. Infect Genet Evol. 2006, 6 (6): 491-504. 10.1016/j.meegid.2006.03.003.CrossRefPubMed
28.
go back to reference Kibiki GS, Mulder B, Dolmans WMV, de Beer JL, Boeree M, Sam N, van Soolingen D, Sola C, van der Zanden AGM: M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania. BMC Microbiol. 2007, 7: 51-10.1186/1471-2180-7-51.CrossRefPubMedPubMedCentral Kibiki GS, Mulder B, Dolmans WMV, de Beer JL, Boeree M, Sam N, van Soolingen D, Sola C, van der Zanden AGM: M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania. BMC Microbiol. 2007, 7: 51-10.1186/1471-2180-7-51.CrossRefPubMedPubMedCentral
29.
go back to reference Eldholm V, Matee M, Mfinanga SGM, Heun M, Dahle UR: A first insight into the genetic diversity of Mycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed by spoligotyping. BMC Microbiol. 2006, 6 (1): 76-10.1186/1471-2180-6-76.CrossRefPubMedPubMedCentral Eldholm V, Matee M, Mfinanga SGM, Heun M, Dahle UR: A first insight into the genetic diversity of Mycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed by spoligotyping. BMC Microbiol. 2006, 6 (1): 76-10.1186/1471-2180-6-76.CrossRefPubMedPubMedCentral
30.
go back to reference Van Laarhoven A, Mandemakers JJ, Kleinnijenhuis J, Enaimi M, Lachmandas E, Joosten LAB, Ottenhoff THM, Netea MG, van Soolingen D, van Crevel R: Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype. Infect Immun. 2013, 81: 3750-3756. 10.1128/IAI.00282-13.CrossRefPubMedPubMedCentral Van Laarhoven A, Mandemakers JJ, Kleinnijenhuis J, Enaimi M, Lachmandas E, Joosten LAB, Ottenhoff THM, Netea MG, van Soolingen D, van Crevel R: Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype. Infect Immun. 2013, 81: 3750-3756. 10.1128/IAI.00282-13.CrossRefPubMedPubMedCentral
31.
go back to reference Cohen T, Wilson D, Wallengren K, Samuel EY, Murray M: Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal. South Africa J Clin Microbiol. 2011, 49 (1): 385-388.CrossRefPubMed Cohen T, Wilson D, Wallengren K, Samuel EY, Murray M: Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal. South Africa J Clin Microbiol. 2011, 49 (1): 385-388.CrossRefPubMed
32.
go back to reference Van Rie A, Victor TC, Richardson M, Johnson R, van der Spuy GD, Murray EJ, Beyers N, van Pittius NC G, van Helden PD, Warren RM: Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med. 2005, 172: 636-642. 10.1164/rccm.200503-449OC.CrossRefPubMedPubMedCentral Van Rie A, Victor TC, Richardson M, Johnson R, van der Spuy GD, Murray EJ, Beyers N, van Pittius NC G, van Helden PD, Warren RM: Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med. 2005, 172: 636-642. 10.1164/rccm.200503-449OC.CrossRefPubMedPubMedCentral
Metadata
Title
Increased level of acute phase reactants in patients infected with modern Mycobacterium tuberculosis genotypes in Mwanza, Tanzania
Authors
Ruth Stavrum
George PrayGod
Nyagosya Range
Daniel Faurholt-Jepsen
Kidola Jeremiah
Maria Faurholt-Jepsen
Henrik Krarup
Martine G Aabye
John Changalucha
Henrik Friis
Aase B Andersen
Harleen MS Grewal
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-309

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.